ClinicalTrials.Veeva

Menu

Impact of Coenzyme Q10 and Selenium on Seminal Fluid and Semen Antioxidant Status

U

University of Sumer

Status

Completed

Conditions

Male Infertility

Treatments

Dietary Supplement: Selenium
Dietary Supplement: Coenzyme Q10

Study type

Interventional

Funder types

Other

Identifiers

NCT03834831
EC/2018/8866

Details and patient eligibility

About

The study was conducted to assess the impact of coenzyme Q10 and selenium on seminal fluid parameters and antioxidant status in infertile men.

Full description

The aim of this study was to assess the impact of coenzyme Q10 and selenium on seminal fluid parameters and antioxidant status in infertile men with idiopathic oligoasthenoteratospermia.

Enrollment

70 patients

Sex

Male

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • History of infertility of at least 12 months despite regular unprotected intercourse.
  • Oligoasthenoteratospermia was diagnosed by semen analysis showing abnormal sperm concentration (<15 million/ml), progressive motility (<32%), total motility (<40%) and morphology (<30% WHO criteria) as defined by WHO manual for semen analysis 2010

Exclusion criteria

  • Azoospermia,
  • Varicocele,
  • Genital tract infection,
  • Cryptorchidism,
  • Testicular trauma or scrotal surgery,
  • Endocrine disorder,
  • Systemic illness,
  • Smoking
  • The presence of female factor

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

70 participants in 2 patient groups

Coenzyme Q10
Active Comparator group
Description:
Coenzyme Q10 200mg/day for 3 months
Treatment:
Dietary Supplement: Coenzyme Q10
Selenium
Active Comparator group
Description:
Selenium mcg/day for 3 months
Treatment:
Dietary Supplement: Selenium

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems